Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 25 November 2019. Steven Grossman.

Executive Summary

The US Senate has settled with the House on another continuing resolution maintaining a 2019 funding level for the FDA and other agencies through 20 December. The Trump administration appears eager to avoid a repeat of last year’s negotiations, which led to a federal shutdown. See what Steven Grossman with the Alliance for a Stronger FDA said about the chances of the government shutting down again this year.

“[US Treasury secretary Steven] Mnuchin said there is no intention on the White House’s part to have a shutdown.” – Steven Grossman, deputy executive director, Alliance for a Stronger FDA

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel